Tinavi Medical Technologies Co., Ltd. (SHA:688277)
China flag China · Delayed Price · Currency is CNY
13.18
-0.78 (-5.59%)
Nov 17, 2026, 3:00 PM CST

SHA:688277 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
261.36272.31172.59206.71145.48145.6
Other Revenue
6.516.516.253.3310.7110.43
267.87278.82178.84210.04156.19156.02
Revenue Growth
-2.31%55.90%-14.85%34.48%0.11%14.80%
Cost of Revenue
90.7186.6554.1871.1154.0250.04
Gross Profit
177.16192.17124.66138.92102.17105.98
Selling, General & Admin
207.36246.09188.11217.47164.98140.57
Research & Development
122.26123.1785.6134.5114.59101.61
Other Operating Expenses
58.563.282.48-3.84-0.3-1.27
Operating Expenses
389.58371.58282.39350.52277.04246.84
Operating Income
-212.42-179.41-157.73-211.6-174.87-140.86
Interest Expense
-6.85-12.16-9.14-6.43-3.95-3.35
Interest & Investment Income
23.566.2441.3958.971.368.73
Currency Exchange Gain (Loss)
-1.11-1.111.160.723.15-0.9
Other Non Operating Income (Expenses)
-14.64-4.64-0.09-0.06-0.04-0.05
EBT Excluding Unusual Items
-211.46-191.08-124.42-158.39-174.36-136.43
Gain (Loss) on Sale of Investments
7.530.670.050.090.10.63
Gain (Loss) on Sale of Assets
0.3-0.055.39-0.03-0.05-0.17
Asset Writedown
2.54-----
Other Unusual Items
61.3835.7819.447.6530.1531.32
Pretax Income
-139.71-154.69-99.55-150.69-144.16-104.65
Income Tax Expense
38.741.4221.5810.61-31.82-22
Earnings From Continuing Operations
-178.41-196.11-121.13-161.3-112.34-82.65
Minority Interest in Earnings
14.1913.36-4.911.752.72
Net Income
-164.22-182.75-121.13-156.39-110.58-79.93
Net Income to Common
-164.22-182.75-121.13-156.39-110.58-79.93
Net Income Growth
------
Shares Outstanding (Basic)
456457449447425421
Shares Outstanding (Diluted)
456457449447425421
Shares Change
0.25%1.84%0.40%5.05%1.10%8.13%
EPS (Basic)
-0.36-0.40-0.27-0.35-0.26-0.19
EPS (Diluted)
-0.36-0.40-0.27-0.35-0.26-0.19
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-199.55-80.88-135.34-391.53-147.1-316.42
Free Cash Flow Per Share
-0.44-0.18-0.30-0.88-0.35-0.75
Gross Margin
66.14%68.92%69.70%66.14%65.42%67.93%
Operating Margin
-79.30%-64.35%-88.20%-100.74%-111.96%-90.28%
Profit Margin
-61.30%-65.54%-67.73%-74.46%-70.80%-51.23%
Free Cash Flow Margin
-74.49%-29.01%-75.68%-186.41%-94.18%-202.80%
EBITDA
-166.99-138.86-123.68-187.6-157.52-130.04
EBITDA Margin
-62.34%-49.80%-69.16%-89.32%-100.85%-83.35%
D&A For EBITDA
45.4340.5534.052417.3510.82
EBIT
-212.42-179.41-157.73-211.6-174.87-140.86
EBIT Margin
-79.30%-64.35%-88.20%-100.74%-111.96%-90.28%
Revenue as Reported
91.34278.82178.84210.04156.19156.02
Advertising Expenses
-5.981.592.271.912.36